Browse Data and Analysis

In September 2024, a National Assembly member submitted a draft revision of the Act on Transboundary Movements of Living Modified Organisms, commonly referred to as the LMO Act.

Colombia’s agricultural industry widely utilizes innovative biotechnologies, and its regulatory environment remains open genetically engineered (GE) derived commodities. However, congressional anti-biotechnology initiatives continue to risk undoing decades of scientific advancement, undermining biotechnology development and potentially impacting agricultural trade.

Korea has not finalized the May 2021 revisions of its Living Modified Organism (LMO) Act, which defines Korea’s regulatory policies for products developed through innovative technologies including genome editing.

While Colombia´s regulatory environment remains friendly toward the adoption of biotechnology-derived crops and products, congressional anti-biotechnology initiatives pose a threat to further acceptance, and risk undermining future investments to benefit consumers and the agricultural sector.

While Colombia's regulatory environment remains friendly toward the adoption of biotech-derived commodities and other innovative technologies, Congressional anti-biotechnology initiatives continue posing a threat, risking the benefits to consumers and the agricultural sector. In 2021, genetically engineered corn area planted grew 31 percent, reaching record figures, and genetically engineered cotton area planted recovered 55 percent compared to 2020.

The Republic of Korea (ROK) has joined international commitments to reach carbon neutrality by 2050 and passed a Carbon Neutrality Act in 2021 to promote green growth. Although the agricultural industry will be relatively less impacted than some other sectors (including energy), agricultural producers will need to make some adjustments.

Colombia remains open to biotechnology and other innovative technologies. In 2020, Colombia's GE corn acreage grew 23 percent while GE cotton acreage declined 37 percent.

Korea is in the process of revising its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

Korea is in the process of drafting a proposal to revise its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

Colombia remains open to the adoption of biotech-derived commodities and innovative technologies.

On April 22, 2020, the Food and Surveillance Institute, INVIMA, issued communication IVC-INS-LI15 which establishes the frequency that importers must present laboratory results...

In April 2019, the Rural Development Administration (RDA) announced the creation of its Center to Commercialize New Breeding Technologies.